摘要
目的评价贝尼地平治疗国人轻中度原发性高血压的疗效与安全性。方法采用多中心、随机、双盲的研究方法,201名轻、中度原发性高血压患者服用安慰剂2周后随机接受贝尼地平或拉西地平治疗,贝尼地平组(99例)起始剂量为2 mg,1次·d-1,拉西地平组(102例)起始剂量为4 mg,1次·d-1,4周后如果血压未达标,将剂量增加至贝尼地平4 mg·d-1,或拉西地平8 mg·d-1。总治疗期间为8周,每2周随访1次,观察降压疗效和不良反应。结果服药4周后贝尼地平组SBP由(152.22±13.77)mmHg降至(137.37±15.96)mmHg,8周时降至(136.72±16.49)mmHg(P<0.01)。4周时DBP由(98.45±3.21)mmHg降至(85.34±9.49)mmHg,8周后DBP为(86.55±9.95)mmHg(P<0.01),降压总有效率74.7%。拉西地平组治疗4周后SBP由(153.59±12.87)mmHg降至(138.94±14.4)mmHg,8周时降至(134.33±13.90)mmHg(P<0.01)。4周时DBP由(98.48±3.63)mmHg降至(85.81±9.30)mmHg,8周后DBP为(85.01±7.79)mmHg(P<0.01),总有效率为78.4%,两组降压疗效比较无显著性差异(P>0.05)。结论贝尼地平与拉西地平比较降压疗效相当,是一种安全有效的降压药,并具有起效缓慢、作用持久、平稳降压的特点,且不良反应轻微。
OBJECTIVE To study effect and safety of benidipine in treatment of Chinese patients with mild to moderate hypertension. METHODS With random and double-blinded method in multicenters, 201 eligible patients aged from 18 to 75 years with mild to moderate hypertension were derided into two groups after received placebo for 2 weeks, 99 patients in experimental group received benidipine 2 mg once a day, 102 patients in control group were given lacidipine 4 rag, once a day for 4 weeks. The dose is adjusted after 4 weeks in the patients not reaching the blood pressure target of DBP or SBP. The whole treatment was continued for 8 weeks, patients must finish one visit every 2 weeks for observing efficacy and adverse events. RESULTS The SBP of the patients in experimen tal group decreased from ( 152. 22 ± 13.77) to ( 137.37± 15.96) mmHg and the DBP from (98.45 ± 3.21 ) to (85.34 ± 9.49) mm Hg after 4 weeks, and DBP was (86. 55 ± 9. 95) mmHg after 8 weeks, the response rate was 74. 7%. In control group, SBP from ( 153.59 ± 12. 87) to ( 138.94± 14.4) mmHg and DBP decreased from (98. 48±3.63 ) to ( 85.81 ± 9. 30) mmHg after 4 weeks, and DBP was (85.01 ±7.79) mmHg after 8 weeks, the response rate was 78, 4%, No significant difference is found between two groups ( P 〉 0. 05 ). CONCLUSION Benidipine and lacidipine have same efficacy to treat hypertension, benidipine is a kind of safe and effective drug to treat hypertension, the action of this drug is stable, persistent and smooth, adverse events are mild.
出处
《中国药学杂志》
CAS
CSCD
北大核心
2014年第15期1342-1344,共3页
Chinese Pharmaceutical Journal
关键词
贝尼地平
拉西地平
高血压病
多中心、随机对照试验
benidipine
lacidopine
hypertension
a muhi center, randomized and placebo-controlled trial